TickerFacts.

Company research / SMNR

Semnur Pharmaceuticals, Inc. (SMNR)

Build a valuation ↗↓ Download CSV

CIK 0001913577 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-10

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312022-01-04
Operating Income-$160.42M-$4.69M-$3.17M——
Net Income-$160.42M-$4.69M$632.5K-$419.4K—
EPS (Diluted)$-0.78$-0.02———
Total Assets$1.35M$6.68M$50.69M$86.28M—
Total Liabilities$22.10M$49.47M$8.49M$4.18M—
Shareholders' Equity-$20.75M-$42.78M-$38.09M-$3.27M$0
Cash & Equivalents$20.0K$12.0K$204.5K$819.7K—
Operating Cash Flow-$5.87M-$4.89M-$632.8K-$426.1K—
Shares Outstanding230.21M200.00M———
Weighted Average Diluted Shares204.78M200.00M———
EPS (Basic)$-0.78$-0.02———